General Resources / Legal Resources / Medical Resources / Briefing Papers / State Activity    
Hospital Closures / Preventable Tragedies / Press Room / Search Our Site / Home

Other Cases


Myers v. Alaska Psychiatric Institute

June 30, 2006

The Alaska Supreme Court determined that the state has a compelling interest, under its parens patriae powers, to treat incompetent individuals with psychotropic medications if that treatment is found to be in the individual’s best interest, while also taking into account available less intrusive alternatives. Because of the broad guarantee of privacy found in the Alaska State Constitution, this determination must be made by an independent judicial review. 

Alaska’s Supreme Court rectified an oversight in their state’s mental health treatment statutes; ensuring that a person’s interests are taken into account when the state exercises its duty to protect an individual from themselves. This commonsense determination is found in many other states and in the Treatment Advocacy Center’s Model Law for Assisted Treatment.

Although this ruling was accompanied by clearly outdated notions about psychotropic medication, TAC is encouraged that treating professionals and courts will have the opportunity to make treatment determinations on an individualized basis. Judges will have the opportunity to explore the most recent evidence about treatment, evidence that amply demonstrates the important role medication plays in effective mental health care.

 


general resources | legal resources | medical resources | briefing papers | state activity   
hospital closures | preventable tragedies | press room | search | home

FootnoteImage2.jpg (1088 bytes)
Treatment Advocacy Center

The contents of TAC's website are copyrighted by the Treatment Advocacy Center unless otherwise indicated. All rights reserved and content may be reproduced, downloaded, disseminated, or transferred, for single use, or by nonprofit organizations for educational purposes only, if correct attribution is made. TAC is an I.R.C. � 501(c)(3) tax-exempt corporation. Donations are appreciated and are eligible for the charitable contribution deduction under the provisions of I.R.C. � 170. Please note that TAC does not accept funding from pharmaceutical companies or entities involved in the sale, marketing, or distribution of such products.

Treatment Advocacy Center (TAC), 200 N. Glebe Road, Suite 730, Arlington, VA 22203
703 294 6001/6002 (phone) | 703 294 6010 (fax) | www.treatmentadvocacycenter.org (website)
[email protected] (general email) | [email protected] (press contact)
[email protected] (webmaster)